Active Biotech AB (STU:BTP) Interest Coverage: No Debt (1) (As of Mar. 2026)


STU:BTP Active Biotech AB STU:BTP
28 GF Score
Price €0.54
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Interest Coverage?

Active Biotech AB STU:BTP 28 Interest Coverage is No Debt (1) as of Mar. 2026. GuruFocus rates STU:BTP with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 377 Biotechnology companies, Active Biotech AB ranks worse than 265251.72% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Active Biotech AB's Operating Income for the three months ended in Mar. 2026 was €-0.80 Mil. Active Biotech AB's Interest Expense for the three months ended in Mar. 2026 was €0.00 Mil. Active Biotech AB has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Active Biotech AB has enough cash to cover all of its debt. Its financial situation is stable.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Active Biotech AB's Interest Coverage or its related term are showing as below:


STU:BTP's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Active Biotech AB  (STU:BTP) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Active Biotech AB Interest Coverage Related Terms


Active Biotech AB Interest Coverage Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Active Biotech AB Interest Coverage Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt N/A No Debt

STU:BTP vs VRTX, REGN, ALNY: Interest Coverage Comparison

For the Biotechnology subindustry, Active Biotech AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Interest Coverage falls into.


STU:BTP
28GF Score
Active Biotech AB STU:BTP
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Active Biotech AB's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Active Biotech AB's Interest Expense was €-0.01 Mil. Its Operating Income was €-3.46 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.01 Mil.

Active Biotech AB did not have earnings to cover the interest expense.

Active Biotech AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Active Biotech AB's Interest Expense was €0.00 Mil. Its Operating Income was €-0.80 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

Active Biotech AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Active Biotech AB (STU:BTP) has a Interest Coverage of No Debt (1) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Active Biotech AB and its competitors. According to the industry distribution chart, Active Biotech AB ranks #999999 out of 377 companies in the Biotechnology industry.
Is Active Biotech AB's Interest Coverage too high?
Active Biotech AB's current Interest Coverage is No Debt (1). Based on the distribution chart, Active Biotech AB ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Active Biotech AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Active Biotech AB ranks #999999 out of 377 companies for Interest Coverage. This places Active Biotech AB in the lower half of its industry. The industry median Interest Coverage is 106.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Active Biotech AB and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Active Biotech AB's current Interest Coverage is No Debt (1). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (STU:BTP) has a current Interest Coverage of No Debt (1). The current Interest Coverage is No Debt (1). Active Biotech AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Active Biotech AB (STU:BTP), the current Interest Coverage is No Debt (1) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for STU:BTP

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.54
Price